JP2016506905A5 - - Google Patents

Download PDF

Info

Publication number
JP2016506905A5
JP2016506905A5 JP2015552077A JP2015552077A JP2016506905A5 JP 2016506905 A5 JP2016506905 A5 JP 2016506905A5 JP 2015552077 A JP2015552077 A JP 2015552077A JP 2015552077 A JP2015552077 A JP 2015552077A JP 2016506905 A5 JP2016506905 A5 JP 2016506905A5
Authority
JP
Japan
Prior art keywords
azide
saccharide
group
spacer
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015552077A
Other languages
English (en)
Japanese (ja)
Other versions
JP6719209B2 (ja
JP2016506905A (ja
Filing date
Publication date
Priority claimed from GBGB1300707.5A external-priority patent/GB201300707D0/en
Application filed filed Critical
Publication of JP2016506905A publication Critical patent/JP2016506905A/ja
Publication of JP2016506905A5 publication Critical patent/JP2016506905A5/ja
Application granted granted Critical
Publication of JP6719209B2 publication Critical patent/JP6719209B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015552077A 2013-01-15 2014-01-13 シクロアルキン誘導体化糖類 Active JP6719209B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1300707.5A GB201300707D0 (en) 2013-01-15 2013-01-15 Compounds and processes
GB1300707.5 2013-01-15
PCT/EP2014/050483 WO2014111344A1 (en) 2013-01-15 2014-01-13 Cycloalkyne derivatized saccharides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018246761A Division JP2019073528A (ja) 2013-01-15 2018-12-28 シクロアルキン誘導体化糖類

Publications (3)

Publication Number Publication Date
JP2016506905A JP2016506905A (ja) 2016-03-07
JP2016506905A5 true JP2016506905A5 (cg-RX-API-DMAC7.html) 2017-02-09
JP6719209B2 JP6719209B2 (ja) 2020-07-08

Family

ID=47758014

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015552077A Active JP6719209B2 (ja) 2013-01-15 2014-01-13 シクロアルキン誘導体化糖類
JP2018246761A Withdrawn JP2019073528A (ja) 2013-01-15 2018-12-28 シクロアルキン誘導体化糖類
JP2020050828A Active JP7036854B2 (ja) 2013-01-15 2020-03-23 シクロアルキン誘導体化糖類

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2018246761A Withdrawn JP2019073528A (ja) 2013-01-15 2018-12-28 シクロアルキン誘導体化糖類
JP2020050828A Active JP7036854B2 (ja) 2013-01-15 2020-03-23 シクロアルキン誘導体化糖類

Country Status (16)

Country Link
US (2) US11135300B2 (cg-RX-API-DMAC7.html)
EP (1) EP2945641B1 (cg-RX-API-DMAC7.html)
JP (3) JP6719209B2 (cg-RX-API-DMAC7.html)
CN (1) CN105377282B (cg-RX-API-DMAC7.html)
BR (1) BR112015016817B1 (cg-RX-API-DMAC7.html)
CA (1) CA2897348C (cg-RX-API-DMAC7.html)
CY (1) CY1122822T1 (cg-RX-API-DMAC7.html)
DK (1) DK2945641T3 (cg-RX-API-DMAC7.html)
ES (1) ES2774729T3 (cg-RX-API-DMAC7.html)
GB (1) GB201300707D0 (cg-RX-API-DMAC7.html)
HR (1) HRP20200351T1 (cg-RX-API-DMAC7.html)
LT (1) LT2945641T (cg-RX-API-DMAC7.html)
PL (1) PL2945641T3 (cg-RX-API-DMAC7.html)
PT (1) PT2945641T (cg-RX-API-DMAC7.html)
SI (1) SI2945641T1 (cg-RX-API-DMAC7.html)
WO (1) WO2014111344A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201300707D0 (en) * 2013-01-15 2013-02-27 Novartis Ag Compounds and processes
SG11201807430WA (en) * 2016-03-04 2018-09-27 Euglena Co Ltd Antiviral agent and antiviral food
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
KR20190103256A (ko) 2016-12-30 2019-09-04 수트로박스, 인코포레이티드 비자연 아미노산을 갖는 폴리펩타이드-항원 접합체
US12050220B2 (en) 2018-02-05 2024-07-30 University Of Miyazaki Cell labeling agent and cell labeling kit
EP3808783A4 (en) 2018-06-14 2022-03-16 Mochida Pharmaceutical Co., Ltd. Novel crosslinked alginic acid
WO2020010016A1 (en) 2018-07-04 2020-01-09 Sutrovax, Inc. Self-adjuvanted immunogenic conjugates
WO2022040266A1 (en) 2020-08-19 2022-02-24 Vaxcyte, Inc. Carrier-protein polysaccharide conjugation methods
BR112023023671A2 (pt) * 2021-05-28 2024-02-06 Pfizer Composições imunogênicas compreendendo antígenos de sacarídeo capsular conjugados e usos dos mesmos
JP2024075506A (ja) * 2022-11-22 2024-06-03 ファイザー・インク コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003080678A1 (en) 2002-03-26 2003-10-02 Chiron Srl Modified saccharides having improved stability in water
AU2005302269B2 (en) 2004-11-01 2011-05-19 The Brigham And Women's Hospital, Inc. Modified streptococcal polysaccharides and uses thereof
GB0502095D0 (en) * 2005-02-01 2005-03-09 Chiron Srl Conjugation of streptococcal capsular saccharides
CN104529711B (zh) * 2007-11-21 2020-02-07 乔治亚大学研究基金公司 炔烃以及炔烃与1,3-偶极-官能化合物反应的方法
ITVI20090234A1 (it) * 2009-09-25 2011-03-26 Termotecniche Fraccaro S R L Off Dispositivo per il riscaldamento di ambienti ad alta efficienza energetica, nonche' sistema riscaldante comprendente tale dispositivo
WO2011079315A1 (en) 2009-12-23 2011-06-30 The Scripps Research Institute Tyrosine bioconjugation through aqueous ene-like reactions
ES2527536T7 (es) 2010-04-27 2016-03-08 Synaffix B.V. Compuestos de ciclooctina fusionada y su uso en reacciones clic sin metales
WO2012017701A1 (ja) * 2010-08-05 2012-02-09 株式会社ミュージックゲート いびき防止マスク
GB201101665D0 (en) * 2011-01-31 2011-03-16 Novartis Ag Immunogenic compositions
US9315468B2 (en) 2010-09-27 2016-04-19 University Of Georgia Research Foundation, Inc. Methods including latent 1,3-dipole-functional compounds and materials prepared thereby
US20120208722A1 (en) * 2010-10-19 2012-08-16 Richard Dluhy Surface enhanced raman spectroscopy platforms and methods
DK2721045T3 (en) 2011-06-20 2017-07-24 Radiomedix Inc COMPOSITIONS, METHODS OF SYNTHESIS AND USE OF CARBOHYDRATE TARGETED AGENTS
AU2012344700A1 (en) * 2011-12-01 2014-06-19 Angiochem Inc. Targeted iduronate-2-sulfatase compounds
GB201300707D0 (en) * 2013-01-15 2013-02-27 Novartis Ag Compounds and processes

Similar Documents

Publication Publication Date Title
JP2016506905A5 (cg-RX-API-DMAC7.html)
WO2008083174A3 (en) Compositions and methods for the treatment of infections and tumors
HRP20200351T1 (hr) Cikloalkinski derivati saharida
CY1125006T1 (el) Λιπαρα οξεα και η χρηση τους σε συνδυασμο με βιομορια
WO2018098269A3 (en) Peptide-containing linkers for antibody-drug conjugates
WO2009082818A8 (en) Novel c-21-keto lupane derivatives preparation and use thereof
WO2009082819A8 (en) Novel lupane derivatives
EP3318562A3 (en) Benzylbenzene derivatives and methods of use
WO2009106980A3 (en) Indazole derivatives
GB201101665D0 (en) Immunogenic compositions
JP2012528865A5 (cg-RX-API-DMAC7.html)
ATE409048T1 (de) Pharmazeutisch aktive oligosaccharid-conjugate
WO2007062107A3 (en) Immunostimulatory oligoribonucleotides
CL2008003153A1 (es) Compuestos espiro condensados, agonistas de gpr40: composicion farmaceutica que comprende a uno de los compuestos; y el uso de los compuestos en la preparacion de medicamentos para el tratamiento de la diabetes, hiperglicemia, alteracion de tolerancia a la glucosa en ayuna, entre otras.
WO2009060281A3 (en) Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
RU2015118581A (ru) Лиофилизированные препараты мелфалана флуфенамида
WO2009088838A3 (en) Triarylmethane analogs and their use in treating cancers
JP2017505777A5 (cg-RX-API-DMAC7.html)
JP2015501329A5 (cg-RX-API-DMAC7.html)
US20230382945A1 (en) Therapeutic agents and methods
RU2013136895A (ru) Новое бициклическое соединение или его соль
RU2012150501A (ru) Противораковые стероидные лактоны, ненасыщенные в положении 7(8)
AR048336A1 (es) Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
WO2015009731A3 (en) Azacyclic constrained analogs of fty720
WO2009102808A3 (en) Doxorubicin adjuvants to reduce toxicity and methods for using the same